SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-18-080671
Filing Date
2018-03-13
Accepted
2018-03-13 16:06:03
Documents
2
Group Members
AMIN NATHOOANSON ADVISORS INC.ANSON MANAGEMENT GP LLCBRUCE R. WINSONMOEZ KASSAM

Document Format Files

Seq Description Document Type Size
1 SC 13G d517923dsc13g.htm SC 13G 115522
2 EX-99.1 d517923dex991.htm EX-99.1 8250
  Complete submission text file 0001193125-18-080671.txt   125621
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Subject) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82467 | Film No.: 18686514
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5950 BERKSHIRE LANE SUITE 210 DALLAS TX 75225
Business Address 5950 BERKSHIRE LANE SUITE 210 DALLAS TX 75225 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

IRS No.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G